Contact

Career
Country websites

Attention

The medical device and therapy related information on this website is aimed exclusively at healthcare professionals.

The product related information on the websites covers – unless explicitly stated otherwise – only CE marked products which are marketable in the European Union. Please be aware that not all products and services described on the following website are cleared or available for sale in all countries. Please check the relevant country web site for details.

By clicking the button “Accepted and Confirmed” you assure that you have taken note of this information.

Back to Homepage Accepted and Confirmed

multiFiltratePRO

Our multi‑modality team player

The multiFiltratePRO has been carefully designed and equipped with a wide range of features intended to support your team in ICU patient care and offer you state-of-the-art therapies. Our device builds on extensive experience with the multiFiltrate and the successfully established Ci‑Ca regional citrate anticoagulation.1‑12

DISCLAIMER

Not all products and services are cleared or available for sale in all EU countries. Check your country web site for details. 

Focusing on your needs

Many critically ill patients in intensive care units (ICUs) are suffering from multi-organ failure and they depend on reliable application of organ support therapies.13

The multiFiltratePRO offers a wide range of therapeutic applications, mostly in intensive care, such as:

 

* Legal manufacturer of multiECCO2R is EUROSETS S.r.l., Italy. Fresenius Medical Care Deutschland GmbH is a distributor of multiECCO2R in selected countries.

HL7 connectivity

Aiming to further enhance the quality of patient care and healthcare operations, multiFiltratePRO enables built-in HL7 connectivity to your PDMS (Patient Data Management System). Efficient and secure device interoperability with the multiFiltratePRO is designed to enable data-driven decision making, streamline workflows and reduce transcription errors.14

DOWNLOAD

pdf

HL7 connectivity flyer

PDF, 300 KB
multiFiltratePRO

With the multiFiltratePRO, Fresenius Medical Care aims to fulfill the requirements of ICU patients as thoroughly as possible, turning it into the ideal team player for your ICU.

Count on us to support you all the way – from the initial implementation of CKRT into your clinical practice to the point of everyday questions in routine application. If you need any help setting up a treatment on the multiFiltratePRO, have a question during an ongoing CKRT treatment or have any technical questions, just call your local support hotline or Fresenius Medical Care representative.

You will have access to a wide range of clinical support from experienced application specialists and our professional sales teams. Diagnostic programs specific to the device as well as our well-trained technicians are the basis for reliable device availability.

Expert meetings, workshops for physicians, and regular educational courses for nurses are optional services we offer to provide you with additional knowledge to apply efficient CKRT.

Explore the multiFiltratePRO

Related content

No Results Found
PREVIOUS
    NEXT

    1 Weidhase L et al. Plos One 2019; 14:e0215823

    2 Eichhorn T et al. Blood Purif 2017; 44:260-266

    3 Weidhase et al. Crit Care 2020; 24:644

    4 Hafner S et al. J Intensive Care 2015; 3:35

    5 Bianchi NA et al. Blood Purif 2020; 49:567-575

    6 Kalb R et al. Ther Apher Dial 2013; 17:202-212

    7 Zarbock A et al. JAMA 2020;324:1629-1639

    8 Morgera et al. Crit Care Med 2009;37:2018-2024

    9 Slowinski T et al. Crit Care 2015; 19:349

    10 Houllé-Veyssière et al. Intensive Crit Care Nurs 2016; 36:35-41

    11 Link A et al. Crit Care 2012; 16:R97

    12 Huguet M et al. Int J Artif Organs 2017; 40:676-682

    13 ICNARC. Case Mix Programme Summary Statistics 2019-20, www.icnarc.org/Our-Audit/Audits/Cmp/Reports/Summary-Statistics, accessed April 2021

    14 Fieler VK, Jaglowski T, Richards K. Eliminating errors in vital signs documentation. Comput Inform Nurs. 2013;31(9):422-427.

    Contact
    Country websites

    All contact information

    Social Media

    © Fresenius Medical Care AG 2024

    Privacy policy

    Cookie settings

    Imprint